ProBiotix Health Plc (OFEX: PBX)
Health Care · Biotechnology · GB
£0.11
+10.53% today · +16.7% 1Y
ProBiotix Health Plc (OFEX: PBX) operates in the Biotechnology industry within the Health Care sector. The company is valued at $22.64M.
Over the last twelve months the share price has gained 16.7%.
Tweenvest scores ProBiotix Health Plc across four factors: quality 44/100, value 42/100, growth 100/100. Its strongest factor is growth.
PBX price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $22.64M
- Revenue (TTM)
- $3.68M
- P/E
- —
- EPS
- -0.01
- Dividend yield
- —
- Beta (5Y)
- -0.03
- 52-week high
- £—
- 52-week low
- £—
- Avg volume (3M)
- —
- Shares outstanding
- 158.17M
- Employees
- —
- Next earnings
- —
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| AbbVie Inc.NYSE: ABBV | $469.68B | $261.53 | -1.60% |
| Amgen Inc.NasdaqGS: AMGN | $239.09B | $440.95 | -0.29% |
| Gilead Sciences, Inc.NasdaqGS: GILD | $184.47B | $147.78 | -0.67% |
| Vertex Pharmaceuticals IncorporatedNasdaqGS: VRTX | $140.13B | $548.74 | -0.74% |
| Regeneron Pharmaceuticals, Inc.NasdaqGS: REGN | $83.24B | $827.02 | -0.78% |
| argenx SEENXTBR: ARGX | $64.17B | €895.40 | +1.84% |
| Moderna, Inc.NasdaqGS: MRNA | $63.41B | $155.61 | -2.03% |
| CSL LimitedASX: CSL | $59.49B | AU$173.64 | +2.68% |
Figures last refreshed Aug 18, 2026.